T. Rowe Price Associates
FRX

T. Rowe Price Associates’s FOREST LABORATORIES INC FRX Stock Holding History

T. Rowe Price Associates’s Portfolio FRX Stock Details FRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,891,682
Closed -$187M – 2611
2014
Q2 		$187M Sell
1,891,682
-684,400
-27% -$63.8M 0.04% 456
2014
Q1 		$238M Sell
2,576,082
-1,006,100
-28% -$81.2M 0.05% 400
2013
Q4 		$215M Sell
3,582,182
-108,700
-3% -$5.47M 0.05% 417
2013
Q3 		$158M Buy
3,690,882
+80,900
+2% +$3.51M 0.04% 463
2013
Q2 		$148M Buy
+3,609,982
New +$139M 0.04% 464

Other funds holding FRX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

T. Rowe Price Associates's FRX Position: Q3 2014 in Review

T. Rowe Price Associates sold out of FOREST LABORATORIES INC (FRX) in Q3 2014, closing a stake of 1,891,682 shares — an estimated $187M sold.

T. Rowe Price Associates first reported a position in FRX in Q2 2013 and held it in 5 quarters. The position peaked at $238M in Q1 2014. 5 funds tracked by Wall St. Rank hold FRX as of Q3 2014.

  • T. Rowe Price Associates reported no remaining FOREST LABORATORIES INC position as of Q3 2014 after selling out during the quarter.
  • T. Rowe Price Associates sold 1,891,682 FOREST LABORATORIES INC shares in Q3 2014, an estimated $187M.
  • T. Rowe Price Associates first reported a position in FOREST LABORATORIES INC in Q2 2013 and held it in 5 quarters.
  • T. Rowe Price Associates's FOREST LABORATORIES INC position peaked at $238M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held FOREST LABORATORIES INC as of Q3 2014.

Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.